Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Guidant releases Ventak Mini in Europe and Canada:

This article was originally published in Clinica

Executive Summary

Guidant (US) and CPI, a division of Guidant's cardiac rhythm management group, have launched the Ventak Mini family of cardioverter defibrillators in Europe and Canada. Guidant says it is the world's smallest full-featured implantable defibrillator. The first implants of the Ventak Mini occurred in Europe and Canada in late August and more than 100 have been implanted worldwide. Guidant has also received FDA approval for its Endotak DSP defibrillation lead for release in the US, where it will be launched in January 1996.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT094442

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel